Differences in connective tissue gene expression between normally functioning, polycystic and post-menopausal ovaries

Molecular Human Reproduction

Volumn 10, Issue 1, 2004, Pages 7-14

  Oksjoki, S ^a   Rahkonen, O ^a   Haarala, M ^a   Vuorio, E ^a   Anttila, Leena ^a,b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b Family Federation of Finland   (Finland)

Author keywords

Extracellular matrix; Human ovary; mRNA; Polycystic ovary syndrome; Post menopause

Indexed keywords

CATHEPSIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; OSTEONECTIN; SCLEROPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MENSTRUAL CYCLE; NORTHERN BLOTTING; OVARY FOLLICLE MATURATION; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; TISSUE DISTRIBUTION; GENETICS; METABOLISM; OVARY;

FALLOPIA;

CONNECTIVE TISSUE; HUMANS; MATRIX METALLOPROTEINASE 9; OVARY; POLYCYSTIC OVARY SYNDROME; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 1042292032     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah003     Document Type: Article

References (46)

1. Ahonen M, Baker AH and Kähäri VM (1998) Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1,2310-2315.
2. Ala-Aho R, Johansson N, Grénman R, Fusenig N, López-Otín C and Kähäri VM (2000) Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-γ is associated with activation of extracellular signal-regulated kinase-12 and STAT1. Oncogene 19,248-257.
3. Auersperg N, Maines-Bandiera SL, Dyck HG and Kruk PA (1994) Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab Invest 71,510-518.
4. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18,5294-5299.
5. Clement PB (2002) Nonneoplastic lesions of the ovary. In Kurman RJ (ed.) Blaustein's Pathology of the Female Genital Tract, 5th edn. Springer, New York, pp. 675-728.
6. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA and Goldberg GI (1988) H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263,6579-6587.
7. Curry TE Jr and Osteen KG (2001) Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 64,1285-1296.
8. Dubois B, Arnold B and Opdenakker G (2000) Gelatinase B deficiency impairs reproduction. J Clin Invest 106,627-628.
9. Fata JE, Leco KJ, Voura EB, Yu HY, Waterhouse P, Murphy G, Moorehead RA and Khokha R (2001) Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest 108,831-841.
10. Faddy MJ (2000) Follicle dynamics during ovarian ageing. Mol Cell Endocrinol 25,43-48.
11. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA and Eisen AZ (1986) Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261,6600-6605.
12. Gomez DE, Alonso DF, Yoshiji H and Thorgeisson UP (1997) Tissue inhibitors of metalloproteinases: structure regulation and biological functions. Eur J Cell Biol 74,111-122.
13. Huet C, Monget P, Pisselet C, Hennequet C, Locatelli A and Monniaux D (1998) Chronology of events accompanying follicular atresia in hypophysectomized ewes. Changes in levels of steroidogenic enzymes connexin 43 insulin-like growth factor II/mannose 6 phosphate receptor extracellular matrix components and matrix metalloproteinases. Biol Reprod 58,175-185.
14. Hulboy DL, Rudolph LA and Matrisian LA (1997) Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 3,27-45.
15. Iruela-Arispe ML, Hasselaar P and Sage H (1991) Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab Invest 64,174-186.
16. Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, Vuorio E, Heino J and Kähäri VM (1997) Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes periosteal cells and osteoblasts during human fetal bone development. Dev Dyn 208,387-397.
17. Khandoker MA, Imai K, Takahashi T and Hashizume K (2001) Role of gelatinase on follicular atresia in the bovine ovary. Biol Reprod 65,726-732.
18. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR and Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83,3078-3082.
19. Kruk PA, Uitto VJ, Firth JD, Dedhar S and Auersperg N (1994) Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp Cell Res 215,97-108.
20. Lahav-Baratz S, Kraiem Z, Shiloh H, Koifman M, Ishai D and Dirnfeld M (2003) Decreased expression of tissue inhibitor of matrix metalloproteinases in follicular fluid from women with polycystic ovaries compared with normally ovulating patients undergoing in vitro fertilization. Fertil Steril 79,567-571.
21. Leco KJ, Waterhouse P, Sanchez OH, Gowing KL, Poole AR, Wakeham A, Mak TW and Khokha R (2001) Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 108,817-829.
22. Mattila L, Airola K, Ahonen M, Hietarinta M, Black C, Saarialho-Kere U and Kähäri VM (1998) Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol 110,416-421.
23. McIntush EW and Smith MF (1998) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. Rev Reprod 3,23-30.
24. Mori Y, Hasumi F, Ito A, Shiina K and Hirakawa S (1984) Collagen and glycosaminoclycans in the human ovarian capsule with polycystic ovarian disease. Gynecol Obstet Invest 18,244-251.
25. Nothnick WB (2000) Disruption of the tissue inhibitor of metalloproteinase-1 gene results in altered reproductive cyclicity and uterine morphology in reproductive-age female mice. Biol Reprod 63,905-912.
26. Ny T, Wahlberg P and Brandstrom IJ (2002) Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol Cell Endocrinol 22,29-38.
27. Oksjoki S, Sallinen S, Vuorio E and Anttila L (1999) Cyclic expression of mRNA transcripts for connective tissue components in the mouse ovary. Mol Hum Reprod 5,803-808.
28. Oksjoki S, Söderström M, Vuorio E and Anttila L (2001) Differential expression patterns of cathepsins B H K L and S in the mouse ovary. Mol Hum Reprod 7,27-34.
29. Pihlajaniemi T, Tryggvason K, Myers JC, Kurkinen M, Lebo R, Cheung MC, Prockop DJ and Boyd CD (1985) cDNA clones coding for the pro-α1(IV) chain of human type IV procollagen reveal an unusual homology of amino acid sequences in two halves of the carboxyl-terminal domain. J Biol Chem 260,7681-7697.
30. Postawski K, Rechberger T, Jakimiuk AJ, Skorupski P, Bogusiewicz M and Jakowicki JA (1999) Interstitial collagenase (MMP-1) activity in human ovarian tissue. Gynecol Endocrinol 13,273-278.
31. Rahkonen OP, Koskivirta IM, Oksjoki SM, Jokinen E and Vuorio EI (2002) Characterization of the murine Timp4 gene localization within intron 5 of the synapsin 2 gene and tissue distribution of the mRNA. Biochim Biophys Acta 19,45-52.
32. Rantakokko J, Aro HT, Savontaus M and Vuorio E (1996) Mouse cathepsin K: DNA cloning and predominant expression of the gene in osteoclasts and in some hypertrophying chondrocytes during mouse development. FEBS Lett 393,307-313.
33. Robinson LL, Sznajder NA, Riley SC and Anderson RA (2001) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary. Mol Hum Reprod 7,641-648.
34. Rodgers RJ and Irving-Rodgers HF (2002) Extracellular matrix of the bovine ovarian membrana granulosa. Mol Cell Endocrinol 31,57-64.
35. Sandberg M, Mäkelä JK, Multimäki P, Vuorio T and Vuorio E (1989) Construction of a human proα1(III)collagen cDNA clone and localization of type III collagen expression in human fetal tissues. Matrix 9,82-91.
36. Shalev E, Goldman S and Ben-Shlomo I (2001) The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women. Hum Reprod 7,325-331.
37. Söderström M, Salminen H, Glumoff V, Kirschke H, Aro H and Vuorio E (1999) Cathepsin expression during skeletal development. Biochim Biophys Acta 1446,35-46.
38. Vuorio T, Mäkeklä JK, Kähäri VM and Vuorio E (1986) Coordinated regulation of type I and type III collagen production and mRNA levels of proα1 (I) and proα2(I) collagen in cultured morphea fibroblasts. Arch Dermatol Res 279,154-160.
39. Wiederanders B, Brömme D, Kirschke H, von Figura K, Schmidt B and Peters C (1992) Phylogenetic conservation of cysteine proteinases. Cloning and expression of a cDNA coding for human cathepsin S. J Biol Chem 5,13708-13713.
40. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA and Goldberg GI (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264,17213-17221.
41. Willis D, Mason H, Gilling-Smith C and Franks S (1998) Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81,302-309.
42. Woessner JF (1982) Uterus cervix and ovary. In Weiss JB and Jayson MIV (eds) Collagen in Health and Disease. Churchill Livingstone, Edinburgh, pp. 506-527.
43. Woessner JF (2001) That impish TIMP: the tissue inhibitor of metalloproteinases-3. J Clin Invest 108,799-800.
44. Yamada S, Fujiwara H, Honda T, Higuchi T, Nakayama T, Inoue T, Maeda M and Fujii S (1999) Human granulosa cells express integrin α2 and collagen type IV: possible involvement of collagen type IV in granulosa cell luteinization. Mol Hum Reprod 5,607-617.
45. Young MF, Day AA, Dominquez P, McQuillan CI, Fisher LW and Termine JD (1990) Structure and expression of osteonectin mRNA in human tissue. Connect Tissue Res 24,17-28.
46. Zhu GG, Stenbäck F, Risteli L, Risteli J and Kauppila A (1993) Organization of type III collagen in benign and malignant ovarian tumors. Cancer 72,1679-1684.